AYTU BioPharma, Inc.
AYTU • NASDAQ • Stock Fundamentals
AYTU BioPharma, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Joshua R. Disbrow, with a market cap of $23.4M.
Market Cap$23.4M
Employees150.0
CEOJoshua R. Disbrow
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
AYTU BioPharma, Inc. FAQ
Common questions about AYTU BioPharma, Inc.
AYTU BioPharma, Inc. (AYTU) has a market capitalization of $23.4M and trades on NASDAQ.
AYTU BioPharma, Inc. has approximately 150 employees.